NO20006111D0 - Urea og karbamater av N-heterocykliske karboksylsyrer og karboksylsyre isostere - Google Patents

Urea og karbamater av N-heterocykliske karboksylsyrer og karboksylsyre isostere

Info

Publication number
NO20006111D0
NO20006111D0 NO20006111A NO20006111A NO20006111D0 NO 20006111 D0 NO20006111 D0 NO 20006111D0 NO 20006111 A NO20006111 A NO 20006111A NO 20006111 A NO20006111 A NO 20006111A NO 20006111 D0 NO20006111 D0 NO 20006111D0
Authority
NO
Norway
Prior art keywords
carbamates
urea
carboxylic acid
heterocyclic
carboxylic acids
Prior art date
Application number
NO20006111A
Other languages
English (en)
Other versions
NO20006111L (no
Inventor
Gregory S Hamilton
Mark H Norman
Yong-Qian Wu
Original Assignee
Guilford Pharm Inc
Amgen Inc Patent Operations M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guilford Pharm Inc, Amgen Inc Patent Operations M filed Critical Guilford Pharm Inc
Publication of NO20006111D0 publication Critical patent/NO20006111D0/no
Publication of NO20006111L publication Critical patent/NO20006111L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/496—Triazoles or their condensed derivatives, e.g. benzotriazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO20006111A 1998-06-03 2000-12-01 Urea og karbamater av N-heterocykliske karboksylsyrer og karboksylsyre isostere NO20006111L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8784498P 1998-06-03 1998-06-03
PCT/US1998/025570 WO1999062879A1 (en) 1998-06-03 1998-12-03 Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres

Publications (2)

Publication Number Publication Date
NO20006111D0 true NO20006111D0 (no) 2000-12-01
NO20006111L NO20006111L (no) 2001-02-01

Family

ID=22207585

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006111A NO20006111L (no) 1998-06-03 2000-12-01 Urea og karbamater av N-heterocykliske karboksylsyrer og karboksylsyre isostere

Country Status (17)

Country Link
US (2) US20020007075A1 (no)
EP (1) EP1082301A1 (no)
JP (1) JP2002516903A (no)
KR (1) KR20010052502A (no)
CN (1) CN1299346A (no)
AU (1) AU1620499A (no)
BG (1) BG105014A (no)
BR (1) BR9815881A (no)
CA (1) CA2333960A1 (no)
EA (1) EA200001246A1 (no)
HU (1) HUP0102847A2 (no)
IL (1) IL140039A0 (no)
NO (1) NO20006111L (no)
PL (1) PL348671A1 (no)
SK (1) SK18292000A3 (no)
WO (1) WO1999062879A1 (no)
ZA (1) ZA9811061B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000302757A (ja) * 1999-04-16 2000-10-31 Shiseido Co Ltd Ｎ−置換ピペリジン誘導体
CN1382140A (zh) 1999-07-09 2002-11-27 奥索-麦克尼尔药品公司 具有神经营养活性的吡咯烷和哌啶、以及含有它们的相关组合物
EE200300168A (et) 2000-10-30 2003-06-16 Janssen Pharmaceutica N.V. Tripeptidüülpeptidaasi inhibiitorid, nende valmistamine ja kasutamine ravimina ning neid sisaldav farmatseutiline kompositsioon
ES2647664T3 (es) 2011-01-04 2017-12-26 Novartis Ag Compuestos de indol o análogos de los mismos útiles para el tratamiento de la degeneración macular relacionada con la edad (AMD)
JP6209605B2 (ja) 2012-06-28 2017-10-04 ノバルティス アーゲー ピロリジン誘導体、および補体経路調節因子としてのその使用
ES2712190T3 (es) 2012-06-28 2019-05-09 Novartis Ag Moduladores de la vía del complemento y sus usos
US9468661B2 (en) 2012-06-28 2016-10-18 Novartis Ag Pyrrolidine derivatives and their use as complement pathway modulators
JP6273274B2 (ja) 2012-06-28 2018-01-31 ノバルティス アーゲー 補体経路モジュレーターおよびその使用
JP6154897B2 (ja) 2012-06-28 2017-06-28 ノバルティス アーゲー ピロリジン誘導体、および補体経路調節因子としてのその使用
KR20150036481A (ko) 2012-07-12 2015-04-07 노파르티스 아게 보체 경로 조절제 및 그의 용도
WO2023090853A1 (ko) * 2021-11-19 2023-05-25 고려대학교 세종산학협력단 신규 우레아계 또는 카바메이트계 p2x7 수용체 길항제 및 이를 유효성분으로 포함하는 주요 우울 장애의 예방 또는 치료용 약학 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151555A (en) * 1979-05-14 1980-11-26 Tanabe Seiyaku Co Ltd Proline derivatives and their production
US4402969A (en) * 1981-03-23 1983-09-06 Merck & Co., Inc. Antihypertensive proline derivatives
DE3134933A1 (de) * 1981-09-03 1983-03-31 Hoechst Ag, 6230 Frankfurt "harnstoffderivate, verfahren zu ihrer herstellung und diese enthaltende medikamente sowie deren verwendung"
JPS58170752A (ja) * 1982-03-30 1983-10-07 Kureha Chem Ind Co Ltd Ｎ−カルバモイルアミノ酸誘導体
DE4228455A1 (de) * 1992-08-26 1994-09-15 Beiersdorf Ag Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Thiolen und/oder Thiolderivaten
US5411991A (en) * 1992-12-22 1995-05-02 Shander; Douglas Method of reducing hair growth employing sulfhydryl active compounds
US5264619B1 (en) * 1993-01-15 1996-05-14 Cosmos Pharm Corp Anti-androgenic cyclo and bicyclo alkenes
US5744485A (en) * 1994-03-25 1998-04-28 Vertex Pharmaceuticals Incorporated Carbamates and ureas as modifiers of multi-drug resistance
US5780484A (en) * 1996-11-13 1998-07-14 Vertex Pharmaceuticals Incorporated Methods for stimulating neurite growth with piperidine compounds
US5935989A (en) * 1996-12-31 1999-08-10 Gpi Nil Holdings Inc. N-linked ureas and carbamates of heterocyclic thioesters

Also Published As

Publication number Publication date
PL348671A1 (en) 2002-06-03
WO1999062879A1 (en) 1999-12-09
BG105014A (en) 2001-08-31
ZA9811061B (en) 1999-12-03
US20020007075A1 (en) 2002-01-17
JP2002516903A (ja) 2002-06-11
CA2333960A1 (en) 1999-12-09
AU1620499A (en) 1999-12-20
EA200001246A1 (ru) 2001-08-27
BR9815881A (pt) 2002-07-23
KR20010052502A (ko) 2001-06-25
IL140039A0 (en) 2002-02-10
HUP0102847A2 (hu) 2001-12-28
WO1999062879A8 (en) 2000-05-04
NO20006111L (no) 2001-02-01
US20020042442A1 (en) 2002-04-11
SK18292000A3 (sk) 2001-07-10
CN1299346A (zh) 2001-06-13
EP1082301A1 (en) 2001-03-14

Similar Documents

Publication Publication Date Title
HUP0105027A3 (en) Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds and their use
EE200000725A (et) Uued 3-arüülpropaanhappe derivaadid ja nende analoogid
PT1070058E (pt) Hidroxiamidas de acido (4-aril-sulfonilamino)-tetra-hidropirano-4-carboxilico
NO924978L (no) Chinolon- og naftyridon-karboksylsyrederivater
NO992403D0 (no) Mikrokapsler av umettede fettsyrer eller fettsyreforbindelser eller blandinger av fettsyrer og/eller fettsyreforbindelser
DE59911005D1 (de) Aminosäureester von arylsulfonamiden und analoga
DE69823016D1 (de) Wässrige lösungen von salicylsaure derivaten
PT0900782E (pt) Ester do acido 2-cianacrilico
NO20006078D0 (no) N-bundete sulfen-amider av N-heterocykliske karboksylsyrer eller karboksylsyre-isostere
PL337698A1 (en) Derivatives of 4-bromo- or iodo-phenylaminobenzhydroxamic acid and their application as mek inhibitors
FI951670A (fi) Joustava antennirakenne ja menetelmä sen valmistamiseksi
ATE196764T1 (de) Kristallform von 5-methylisoxazol-4-carbonsäure- (4-trifluormethyl)-anilid
NO20006111D0 (no) Urea og karbamater av N-heterocykliske karboksylsyrer og karboksylsyre isostere
NO975037D0 (no) Preparat omfattende amoxycillin og clavulansyre
DE59709031D1 (de) Stabile wässrige formulierung von 3-(n-butylacetamino)-propionsäureethylester
NO996366L (no) Arylkarboksylsyre- og tetrazolderivater
DE59913680D1 (de) Fettsäurepartialester von Polyolen
DE59712000D1 (de) Herstellung von Carbonsäurefluoriden
NO960414L (no) Anvendelse av fenylcykloheksylkarboksylsyreamider
EE9900541A (et) Toiduhappe tootmine
NO992751D0 (no) N-bundet urea og karbamater av heterocykliske tiolestere
ID25536A (id) Metode pembuatan asam-asam 4-fenil-4-sianosikloheksanoat tersubstitusi
DK1228026T3 (da) 15-Hydroxyicosatetraensyrerelaterede forbindelser og fremgangsmåde til anvendelse
DE69707251T2 (de) Maleimidobenzosäure Ester
DE59803990D1 (de) Verwendung von fettsäurepolyglycolestersulfaten

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application